Evidence map›Paper›PMID 37593761›Full record

ArticleFrontiers in cellular and infection microbiology2023

Elucidating colorectal cancer-associated bacteria through profiling of minimally perturbed tissue-associated microbiota.

Hironori Fukuoka, Dieter M Tourlousse, Akiko Ohashi, Shinsuke Suzuki, Kazuya Nakagawa, Mayumi Ozawa, Atsushi Ishibe, Itaru Endo, Yuji Sekiguchi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hironori FukuokaDepartment of Gastroenterological Surgery, Yokohama City University Hospital, Yokohama, Japan.
Dieter M TourlousseBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
Akiko OhashiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
Shinsuke SuzukiDepartment of Surgery, Fujisawa Shonandai Hospital, Fujisawa, Japan.
Kazuya NakagawaDepartment of Gastroenterological Surgery, Yokohama City University Hospital, Yokohama, Japan.
Mayumi OzawaDepartment of Gastroenterological Surgery, Yokohama City University Hospital, Yokohama, Japan.
Atsushi IshibeDepartment of Gastroenterological Surgery, Yokohama City University Hospital, Yokohama, Japan.
Itaru EndoDepartment of Gastroenterological Surgery, Yokohama City University Hospital, Yokohama, Japan.
Yuji SekiguchiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
National Institute of Advanced Industrial Science and Technology · JPYokohama City University · JPYokohama City University Hospital · JPFujisawa City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequencing-based interrogation of gut microbiota is a valuable approach for detecting microbes associated with colorectal cancer (CRC); however, such studies are often confounded by the effect of bowel preparation. In this study, we evaluated the viability of identifying CRC-associated mucosal bacteria through centimeter-scale profiling of the microbiota in tumors and adjacent noncancerous tissue from eleven patients who underwent colonic resection without preoperative bowel preparation. High-throughput 16S rRNA gene sequencing revealed that differences between on- and off-tumor microbiota varied considerably among patients. For some patients, phylotypes affiliated with genera previously implicated in colorectal carcinogenesis, as well as genera with less well-understood roles in CRC, were enriched in tumor tissue, whereas for other patients, on- and off-tumor microbiota were very similar. Notably, the enrichment of phylotypes in tumor-associated mucosa was highly localized and no longer apparent even a few centimeters away from the tumor. Through short-term liquid culturing and metagenomics, we further generated more than one-hundred metagenome-assembled genomes, several representing bacteria that were enriched in on-tumor samples. This is one of the first studies to analyze largely unperturbed mucosal microbiota in tissue samples from the resected colons of unprepped CRC patients. Future studies with larger cohorts are expected to clarify the causes and consequences of the observed variability in the emergence of tumor-localized microbiota among patients.

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeMicrobiotaBacteriaHumansRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNA gene amplicon sequencingbowel preparationcolorectal cancermetagenome-assembled genomesmucosal microbiotaunprepped colon resection

Identifiers

PMID37593761
PMCPMC10432157
OpenAlexW4385454129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.